News
Sage wilts as Huntington's prospect flunks trial
Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for Huntington's disease
News
MSD says subcutaneous Keytruda matches IV form
A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.
News
NIH algorithm matches patients to clinical trials
Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of volunteers into clinical trials, aiming to solve a major obstacle in clin
News
GSK drug raises hopes for patients with PBC itch
GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver disease primary biliary cholangitis (PBC).
News
J&J plots filings after psoriasis drug clears phase 3 test
Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
